-
Wedbush Reiterates "Outperform" Rating for Spyre Therapeutics (NASDAQ:SYRE)
ソース: Buzz FX / 09 11 2024 22:16:18 America/New_York
Wedbush Reiterates "Outperform" Rating for Spyre Therapeutics (NASDAQ:SYRE) Written by MarketBeat November 9, 2024 Share Link copied to clipboard. Spyre Therapeutics ( NASDAQ:SYRE - Get Free Report ) 's stock had its "outperform" rating res
Read more...